Unicycive Therapeutics logo

Unicycive Therapeutics share price today

(UNCY)

Unicycive Therapeutics share price is $0.68 & ₹57.78 as on 21 Dec 2024, 2.30 'hrs' IST

$0.68

-0.03

(-3.66%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Unicycive Therapeutics share price in Dollar and Rupees. Guide to invest in Unicycive Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Unicycive Therapeutics. Get details on the Indian mutual funds that are investing in Unicycive Therapeutics. Get Analyst recommendations and forecasts along with all the Unicycive Therapeutics's financials.

Unicycive Therapeutics share price movements

  • Today's Low: $0.68
    Today's High: $0.74

    Day's Volatility :8.11%

  • 52 Weeks Low: $0.20
    52 Weeks High: $1.82

    52 Weeks Volatility :88.89%

Unicycive Therapeutics Returns

PeriodUnicycive Therapeutics IncIndex (Russel 2000)
3 Months
60.79%
0.0%
6 Months
0.19%
0.0%
1 Year
17.93%
0.0%
3 Years
-66.96%
-19.7%

Unicycive Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.71
Open
$0.72
Today's High
$0.74
Today's Low
$0.68
Market Capitalization
$73.7M
Today's Volume
$1.3M
52 Week High
$1.818
52 Week Low
$0.202
Revenue TTM
$0.0
EBITDA
$-28.8M
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-121.76%

How to invest in Unicycive Therapeutics from India?

It is very easy for Indian residents to invest directly in Unicycive Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Unicycive Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Unicycive Therapeutics or UNCY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Unicycive Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Unicycive Therapeutics shares which would translate to 1.250 fractional shares of Unicycive Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Unicycive Therapeutics, in just a few clicks!

Returns in Unicycive Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Unicycive Therapeutics investment value today

Current value as on today

₹1,19,437

Returns

₹19,437

(+19.44%)

Returns from Unicycive Therapeutics Stock

₹17,241 (+17.24%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Unicycive Therapeutics

2866.67%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Unicycive Therapeutics from India has grown in the last 30 days as on Dec 21, 2024. 2866.67% more purchase transactions for Unicycive Therapeutics in the last 30 days versus the previous period.

442%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Unicycive Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 442% more investors are searching Unicycive Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Unicycive Therapeutics

  • Octagon Capital Advisors LP

    8.25%

  • Logos Global Management LP

    4.89%

  • Walleye Trading Advisors, LLC

    4.82%

  • Vivo Capital, LLC

    4.31%

  • SILVERARC CAPITAL MANAGEMENT, LLC

    3.85%

  • Nantahala Capital Management, LLC

    2.72%

Analyst Recommendation on Unicycive Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Unicycive Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
9
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Unicycive Therapeutics

What analysts predicted

Upside of 708.82%

Current:

$0.68

Target:

$5.50

Insights on Unicycive Therapeutics

  • Price Movement

    In the last 1 month, UNCY stock has moved up by 29.6%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 951.0K → -271.0K (in $), with an average decrease of 84.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 3.93M → -4.09M (in $), with an average decrease of 204.2% per quarter
  • UNCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 15.5%
  • UNCY vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 90.4%

Unicycive Therapeutics Technicals Summary

Sell

Neutral

Buy

Unicycive Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Unicycive Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Unicycive Therapeutics Inc
29.59%
0.19%
17.93%
-66.96%
-88.31%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Unicycive Therapeutics Inc
NA
NA
NA
-0.53
-1.22
-0.53
NA
-0.11
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Unicycive Therapeutics Inc
Buy
$73.7M
-88.31%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Unicycive Therapeutics

unicycive therapeutics is passionate about treating kidney diseases with significant unmet medical needs.
Organization
Unicycive Therapeutics
Employees
14
CEO
Dr. Shalabh K. Gupta M.D., MPA
Industry
Miscellaneous

Management People of Unicycive Therapeutics

NameTitle
Dr. Shalabh K. Gupta M.D., MPA
Founder, Chairman, CEO & President
Dr. Pramod Gupta Ph.D.
Executive Vice President of Pharmaceutical & Business Operations
Mr. Douglas Jermasek M.B.A.
Executive Vice President of Corporate Strategy
Mr. John W. Townsend CPA
Chief Financial Officer

Important FAQs about investing in Unicycive Therapeutics from India :

What is Unicycive Therapeutics share price today?

Unicycive Therapeutics share price today stands at $0.68, Open: $0.72 ; Previous Close: $0.71 ; High: $0.74 ; Low: $0.68 ; 52 Week High: $1.82 ; 52 Week Low: $0.20. The stock opens at $0.72, after a previous close of $0.71. The stock reached a daily high of $0.74 and a low of $0.68, with a 52-week high of $1.82 and a 52-week low of $0.20.

Can Indians buy Unicycive Therapeutics shares?

Yes, Indians can invest in the Unicycive Therapeutics (UNCY) from India.

With INDmoney, you can buy Unicycive Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Unicycive Therapeutics at zero transaction cost.

How can I buy Unicycive Therapeutics shares from India?

It is very easy to buy Unicycive Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Unicycive Therapeutics be purchased?

Yes, you can buy fractional shares of Unicycive Therapeutics with INDmoney app.

What are the documents required to start investing in Unicycive Therapeutics stocks?

To start investing in Unicycive Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Unicycive Therapeutics

Today’s highest price of Unicycive Therapeutics (UNCY) is $0.74.

Today’s lowest price of Unicycive Therapeutics (UNCY) is $0.68.

What is today's market capitalisation of Unicycive Therapeutics

Today's market capitalisation of Unicycive Therapeutics UNCY is 73.7M

What is the 52 Week High and Low Range of Unicycive Therapeutics

  • 52 Week High

    $1.82

  • 52 Week Low

    $0.20

What are the historical returns of Unicycive Therapeutics?

  • 1 Month Returns

    29.59%

  • 3 Months Returns

    0.19%

  • 1 Year Returns

    17.93%

  • 5 Years Returns

    -88.31%

Who is the Chief Executive Officer (CEO) of Unicycive Therapeutics

Dr. Shalabh K. Gupta M.D., MPA is the current Chief Executive Officer (CEO) of Unicycive Therapeutics.